-65.7%
MRNA vs NTAP
+140.4%
-206.1%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +8.5% | -3.2% | +3.3% |
| 7D | -1.1% | +7.4% | -8.5% | -2.8% |
| 30D | +126.1% | -1.4% | +127.5% | +124.5% |
| 3M | +190.0% | +24.6% | +165.5% | +160.4% |
| 6M | +157.2% | +105.9% | +51.3% | +79.9% |
| YTD | +388.2% | +88.5% | +299.7% | +252.7% |
| 1Y | +467.0% | +62.1% | +404.9% | +340.5% |
| 3Y | +36.1% | +169.1% | -133.0% | -21.5% |
| All | -65.7% | +140.4% | -206.1% | -80.4% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling